EU rejects Bitetech, Pfizer vaccine approval

The European Barnas Agency rejected the demand of German pharmaceutical company Bitonech and American partner Pfizer for conditional approval of the vaccine against the coronary virus. The European Barnas Agency will give its opinion on the vaccine at the meeting on December 29th, and after that, the thought will be forwarded to member states for approval, the Financial Times writes. [...]
The European Barnas Agency rejected the demand of German pharmaceutical company Bitonech and American partner Pfizer for conditional approval of the vaccine against the coronary virus.
The European Barnas Agency will give its opinion on the vaccine at the meeting on December 29th, and after that, the thought will be forwarded to member states for approval, the Financial Times writes.
This potentially delays the distribution of vaccines in the EU by the beginning of next year.
The assessment of rival Moderna's vaccine has been postponed for January 12th, 2021.
German Health Minister Jens Spahn earlier announced that the vaccine could begin before the end of this year, but after the denied request, he redirected the prognosis early next year.
“
The vaccine will not be available for the wide population until early summer.











